Immune response biomarker profiling of serum from prostate cancer patients treated with anti-CTLA-4 immunotherapy.

ABSTRACT: Anti-CTLA-4 induced antibody responses to antigens in prostate cancer patients. Pre-treatment and post-treatment sera from 5 clinical responders and 6 clinical non-responders were used to hybridize protein arrays.

ORGANISM(S): Homo sapiens

SUBMITTER: Serena Kwek 

PROVIDER: E-GEOD-39688 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress